Company / CapEx per Share
Kiniksa Pharmaceuticals International, plc CapEx per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.02
FY2025
5-year range
$0.00 / $0.06
FY2021-FY2025
Trend
+454.2%
vs FY2024
Sector context
#100 of 192
Health Care
What the data says
CapEx per Share changed +454% YoY in FY2025, a notable deviation from the 8-year average annual change of +235%.
Based on SEC 10-K filings.
0.02 in FY2025 with a 5-year CAGR of +36.6%.
Improved from $0.00 to $0.02 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +134.2%
- 5-Year CAGR
- +36.6%
- 10-Year CAGR
- -
Sector benchmark
#100 of 192 in Health CareTop 52% of 192This company $0.02 Sector average $2.46
▼
-99.1% below sector average
Key checks
Key Insights
- Kiniksa Pharmaceuticals International, plc's capex per share has grown for 3 consecutive years.
- In FY2025, capex per share increased 454.2% year-over-year.
- Ranks #100 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2018.
Company context
Key Data Points
- Negative profit margin: -10.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.02 | +454.2% |
| FY2024 | $0.00 | +107.5% |
| FY2023 | $0.00 | +11.7% |
| FY2022 | $0.00 | -97.1% |
| FY2021 | $0.06 | +1195.0% |
| FY2020 | $0.00 | -92.3% |
| FY2019 | $0.06 | -66.9% |
| FY2018 | $0.18 | +369.6% |
| FY2017 | $0.04 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026